Hlin Kvartsberg

Karolinska Institutet Science Park
Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory.

Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory.

Journal: Clinical chemistry and laboratory medicine

Published: March 10, 2026

Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months.

Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months.

Journal: Journal of neurology

Published: January 16, 2026

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis.

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis.

Journal: European journal of neurology

Published: January 09, 2026

Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds.

Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 15, 2025

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Journal: Acta neuropathologica

Published: October 13, 2025

Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation.

Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 26, 2025

Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonization.

Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonization.

Journal: Clinical chemistry and laboratory medicine

Published: September 11, 2025

Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay.

Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay.

Journal: Journal of neurology

Published: July 25, 2025

Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation.

Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation.

Journal: Clinical chemistry and laboratory medicine

Published: July 11, 2025

Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

Journal: Clinical chemistry

Published: June 16, 2025

Method comparison of plasma and CSF GFAP immunoassays across multiple platforms.

Method comparison of plasma and CSF GFAP immunoassays across multiple platforms.

Journal: Clinical chemistry and laboratory medicine

Published: June 02, 2025

Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

Journal: Acta neuropathologica

Published: April 21, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026